The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 290.00
Bid: 284.00
Ask: 289.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.761%)
Open: 290.00
High: 0.00
Low: 0.00
Prev. Close: 290.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Thu, 04th Jun 2020 13:19

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and not separately reported by Alliance News:

----------

Open Orphan PLC - pharmaceutical services - Launches antibody testing service, hVIVO Covid Clear Test, following the successful completion of installation, testing and training. Test will be offered to large employer groups and channel partners including GP networks, nursing services, health clinics and private hospitals. Samples will be tested in the company's London laboratory with results returned within 48 hours.

----------

PureTech Health PLC - biotherapeutics - Founded entity Follica reports positive feedback from an end of Phase 2 meeting with the US Food & Drug Administration for its lead programme to treat male androgenetic alopecia. Follica plans to advance the programme into phase 3 development in 2020 following the successful safety and efficacy optimisation study announced in December 2019.

----------

Hutchison China Meditech Ltd - biopharmaceutical - Independent Data Monitoring Committee of the Frutiga study of fruquintinib has completed a planned interim data review and has recommended continuation of the trial. Frutiga is a phase III trial in China of fruquintinib in combination with paclitaxel in the treatment of patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed after first-line standard chemotherapy.

----------

Oncimmune Holdings PLC - immunodiagnostics - Revenue to be in line with market expectations for year to May 31, with further strong growth expected in financial 2021. Cash at year-end expected to be GBP4.2 million and net debt of GBP3.1 million. Next 18 months expected to create substantial revenues within the EarlyCDT product business. Pipeline of contracts within the ImmunoInsights services business building. Geoffrey Hamilton-Fairley, non-executive vice chair; Julian Hirst, independent non-executive director; and Carsten Schroeder, independent non-executive director, have stepped down with immediate effect following board restructuring.

----------

Loungers PLC - bars and restaurants - Opened 17 sites for take-out and will open a further 10 sites on the same basis over the next week. Choses not to go down the delivery route. Looking to trial order-at-table technology and considering menu size. Plans to trial going cashless after re-opening. Anticipating some of sites being allowed to open in July. Expects to trade profitably with social distancing rules in place.

----------

Personal Group Holdings PLC - employee benefits - Too early to accurately assess eventual impact of Covid-19 on the company. Made an encouraging start to 2020. Switched salesforce to telesales to retain and recapture insurance policyholders. Introduced new company-wide pandemic insurance product for clients. Paying out on Covid-19 claims and supporting bereaved families and hospitalised policyholders. Negotiating significant potential new Let's Connect and Insurance clients.

----------

XP Power Ltd - power control components - All manufacturing and logistics facilities currently operational. Operational performance continuing to improve following the extended shutdown of Chinese manufacturing facility in February, and the associated supply chain challenges. Local supply chains in China and Vietnam are working at pre-Covid-19 capacity levels. Trading during April and May encouraging. Order intake in April and May continues to be strong. Sees exceptional levels of demand from its Healthcare customers. Expects this demand to normalise in second half of 2020. Revenue for five months to May-end up 7% year-on-year at GBP86.3 million. Year-to-date orders up 52% at GBP128.0 million. Net debt GBP38.0 million at May 31. Good near-term visibility due to strong order book.

----------

Randall & Quilter Investment Holdings Ltd - insurance - Completes loss portfolio transfer from Houston International Insurance Group. Agreement provides reinsurance protection and limited adverse development cover for circa USD95 million of net reserves of three companies in Houston International - Houston Specialty Insurance Co, Imperium Insurance Co and Great Midwest Insurance Co. The reserves relate to the companies' 2017 and prior policy years for certain portfolios.

----------

Clear Leisure PLC - investments - Shareholder Eufingest SA agreed to extend repayment of loans worth EUR3.9 million and GBP30,000 to September 30 or such earlier date as may be agreed with Clear Leisure.

----------

Kazera Global PLC - investment - Acquires a controlling interest in a near-term producing diamond mine and in a heavy mineral sands opportunity in South Africa. To buy a 90% stake in Deep Blue Minerals (Pty) Ltd and a stake in Whale Head Minerals (Pty) Ltd. Acquisition cost of the stake in Deep Blue Minerals is GBP600,000 funded via issue of 120 million ordinary shares at 0.5 pence each. To buy a stake in Whale Head Minerals representing 90% of its issued capital. To assume USD500,000 of liabilities from the vendor of the shares in Whale Head Minerals.

----------

Cluff Natural Resources PLC - natural resources investments - Fully committed to drilling Pensacola and Selene prospects in UK North Sea. To begin farm-out process on a further two of its licences in the second half of 2020. Applied for multiple licences in the UK 32nd offshore licensing round, with results expected this summer. In a strong financial position with cash of GBP13.2 million as at March 31. Will review opportunities, including the potential to acquire cash generative production portfolios. To seek shareholder approval to rename itself Deltic Energy PLC.

----------

Pure Gold Mining Inc - mining - Drilling restarts at PureGold Red Lake mine in Red Lake, Canada. Over 30,000 meters of diamond drilling, including both underground and surface drilling, is planned to optimize the near term mine plan, expedite the growth of our mineral resources and aggressively expand new high-grade discoveries. Over 30,000 meters of diamond drilling, including both underground and surface drilling, planned to optimize the near term mine plan, expedite the growth of our mineral resources and aggressively expand new high-grade discoveries.

----------

Hummingbird Resources PLC - gold mining - Inks earn-in agreement with ARX Resources Ltd for the company's Dugbe Gold project located in Liberia. Pact requires ARX completing a definitive feasibility study, carry out a significant exploration programme and cover all project costs over the two year earn-in period. Earn-in entitles ARX to earn up to a 49% interest in the project, and includes the payment by ARX to Hummingbird of a non-refundable deposit of USD2 million. Hummingbird secures the right to acquire an exploration licence in Liberia, which is surrounded on all sides by the company's existing mineral development agreement.

----------

Blackbird PLC - cloud video editing platform - Sports and live event production specialist Whisper has chosen Blackbird to drive major video production efficiencies for its clients, including Formula One. Whisper production team will use Blackbird's toolset to remotely edit and enrich documentaries, interviews and behind-the-scenes long form content.

----------

Codemasters Group Holdings PLC - video games - To release Project CARS 3 game in late summer 2020 for PlayStation 4 and the Xbox One family of devices.

----------

Elecosoft PLC - architectural and engineering software - Revenue for four months to April 30 down 3% year-on-year. Recurring maintenance, support and subscription revenue 6% higher. Pretax profit up 25% year-on-year. Net cash of GBP3.1 million at April 30.

----------

CyanConnode Holdings PLC - machine-to-machine communication - Substantial contract from Indian utility, Jaipur Vidyut Vitran Nigam Ltd, relating to two projects, which had been delayed, has now received the necessary approvals to resume the implementation. Further steps taken to reduce cost base amid virus disruption. Thai contract continues to meet project deliverables and payments were received from the customer at the end of March and May.

----------

Van Elle Holdings PLC - ground engineering - Appoints former Galliford Try PLC's chief financial officer Frank Nelson as a non-executive director and chair designate, replacing outgoing Adrian Barden. April trading consistent with revised assumptions, with revenue at 20% of pre Covid-19 forecast levels. Revenue for year to April 30 down 4% year-on-year at GBP85 million. To report an underlying pre-tax loss for financial 2020 due to a significant adverse impact from virus outbreak. Not appropriate to reinstate guidance for financial 2021. Customer activity levels beginning to increase. Order book at April 30 in line with the half year position at GBP31.7 million, although enquiry levels have reduced by circa 20% compared to previous levels. Cash of GBP12 million at May 31. In talks for additional debt facilities.

----------

Dillistone Group PLC - recruitment technology - Gets GBP1.5 million under UK government's coronavirus loan scheme. To use loan for working capital purposes, including development of existing and new products. Range of likely outcomes for 2020 has significantly improved. Too early to quantify the impact of the pandemic over 2020, however, the most likely outcome for first half will be a small loss.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Aug 2022 09:17

Hutchmed regulatory submission underway as fruquintinib trial succeeds

(Alliance News) - Hutchmed Ltd on Monday announced phase 3 of its fruquintinib FRESCO-2 study met its primary endpoint.

Read more
1 Aug 2022 15:16

TRADING UPDATES: Belvoir, Ingenta revenue up; Symphony revenue down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jul 2022 15:59

UK earnings, trading statements calendar - next 7 days

Tuesday 26 July 
Aberforth Smaller Companies Trust PLCHalf Year Results
Ascential PLCHalf Year Results
Bytes Technology Group PLCTrading Statement
Capital & Counties Properties PLCHalf Year Results
Cohort PLCFull Year Results
Compass Group PLCTrading Statement
Dotdigital Group PLCTrading Statement
Drax Group PLCHalf Year Results
easyJet PLCTrading Statement
Ergomed PLCTrading Statement
Franchise Brands PLCHalf Year Results
Games Workshop Group PLCFull Year Results
Gore Street Energy Storage Fund PLCFull Year Results
Greencore Group PLCQ3 Results
John Menzies PLCTrading Statement
Medica Group PLCTrading Statement
Mitie Group PLCTrading Statement
NewRiver REIT PLCTrading Statement
Playtech PLCTrading Statement
Reach PLCHalf Year Results
Ricardo PLCTrading Statement
Sabre Insurance Group PLCHalf Year Results
SME Credit Realisation Fund LtdFull Year Results
Trifast PLCFull Year Results
Tyman PLCHalf Year Results
Unilever PLCHalf Year Results
Vivo Energy PLCHalf Year Results
Wickes Group PLCTrading Statement
Wednesday 27 July 
Aptitude Software Group PLCHalf Year Results
BlackRock Energy & Resources Income Trust PLCHalf Year Results
Breedon Group PLCHalf Year Results
British American Tobacco PLCHalf Year Results
FirstGroup PLCTrading Statement
Fresnillo PLCQ2 Production Results
GSK PLCHalf Year Results
Hargreaves Services PLCFull Year Results
Hiscox LtdTrading Statement
Ibstock PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Lancashire Holdings LtdHalf Year Results
Lloyds Banking Group PLCHalf Year Results
Marston's PLCTrading Statement
Motorpoint Group PLCTrading Statement
musicMagpie PLCHalf Year Results
Nichols PLCHalf Year Results
Primary Health Properties PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Reckitt Benckiser Group PLCHalf Year Results
Rio Tinto PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCHalf Year Results
Wizz Air Holdings PLCQ1 Results
Yourgene Health PLCFull Year Results
Thursday 28 July 
Airtel Africa PLCTrading Statement
Anglo American PLCHalf Year Results
Aveva Group PLCTrading Statement
BAE Systems PLCHalf Year Results
Barclays PLCHalf Year Results
Bodycote PLCHalf Year Results
BT Group PLCQ1 Results
Centrica PLCHalf Year Results
CVS Group PLCTrading Statement
De La Rue PLCTrading Statement
Diageo PLCFull Year Results
discoverIE Group PLCTrading Statement
Dr Martens PLCTrading Statement
Elementis PLCHalf Year Results
FDM Group PLCHalf Year Results
Forterra PLCHalf Year Results
Foxtons Group PLCHalf Year Results
GB Group PLCTrading Statement
Greencoat UK Wind PLCHalf Year Results
Hammerson PLCHalf Year Results
Headlam Group PLCTrading Statement
Inchcape PLCHalf Year Results
Indivior PLCHalf Year Results
Informa PLCHalf Year Results
ITV PLCHalf Year Results
Jupiter Fund Management PLCHalf Year Results
Logistics Development Group PLCTrading Statement
Metro Bank PLCHalf Year Results
Mitchells & Butlers PLCTrading Statement
Mortgage Advice Bureau (Holdings) PLCTrading Statement
Mothercare PLCFull Year Results
MySale Group PLC Trading Statement
National Express Group PLCHalf Year Results
Quixant PLCTrading Statement
Rathbones Group PLCHalf Year Results
Relx PLCHalf Year Results
Rentokil Initial PLCHalf Year Results
Restore PLCHalf Year Results
Robert Walters PLCHalf Year Results
Schroders PLCHalf Year Results
Segro PLCHalf Year Results
Shell PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
St James's Place PLCHalf Year Results
Vesuvius PLCHalf Year Results
Volex PLCHalf Year Results
Weir Group PLCHalf Year Results
Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Spectris PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
15 Jul 2022 13:20

IN BRIEF: Hutchmed starts phase I trial of HMPL-A83

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Begins phase I trial of HMPL-A83 for patients with advanced malignant neoplasms, in China. HMPL-A83 is an investigational novel IgG4-type humanized anti-CD47 monoclonal antibody. Malignant neoplasms are cancerous tumours. It has "significant" potential to be used as a combination therapy with Hutchmed's existing portfolio, the firm says.

Read more
13 Jul 2022 09:35

IN BRIEF: Hutchmed presents solid results from lung cancer study

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Presents positive results from the Savannah phase two trial of Hutchmed and AstraZeneca PLC's savolitinib in combination with Astra's osimertinib in epidermal growth factor receptor-mutated non-small cell lung cancer patients.

Read more
6 Jul 2022 10:37

AIM WINNERS & LOSERS: Hutchmed down amid China Covid woes; Parkmead up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
6 Jul 2022 09:25

Hutchmed phase I trial for IMG-007 doses first patient

(Alliance News) - Hutchmed China Ltd on Wednesday announced the first patient has been dosed for its phase I trial for IMG-007.

Read more
1 Jun 2022 10:07

IN BRIEF: Hutchmed China wins cancer drug Tazverik approval in Hainan

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Receives approval for Tazverik from the Health Commission & Medical Products Administration of the Hainan province in China. The approval is for use in the Hainan pilot zone under the Clinically Urgently Needed Imported Drugs scheme, for the treatment of certain patients with epithelioid sarcoma and follicular lymphoma.

Read more
3 May 2022 12:14

LONDON MARKET MIDDAY: Stocks down as aggressive US Fed rate hike looms

(Alliance News) - Stock prices in London were lower at midday on Tuesday following the long bank holiday weekend in the UK, as markets globally prepare for a sharp US interest rate hike and similar moves by other central banks as they struggle to control inflation.

Read more
3 May 2022 11:29

AIM WINNERS & LOSERS: Hutchmed sinks on US FDA drug rejection

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
3 May 2022 11:25

IN BRIEF: US FDA says Hutchmed's pancreatic drug needs more testing

Hutchmed (China) Ltd - Hong Kong-based biopharmaceuticals - The US Food & Drug Administration has rejected Hutchmed's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA says the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively. Chief Executive Officer & Chief Scientific Officer Weiguo Su comments: "Although this decision from the FDA is disappointing, we remain confident about the clinical value of surufatinib for NET patients and committed to making surufatinib available to patients globally. We look forward to working with the agency to evaluate its feedback."

Read more
3 May 2022 08:57

LONDON MARKET OPEN: BP rises despite taking hit from Rosneft exit

(Alliance News) - Stock prices in London opened lower on Tuesday following the long bank holiday weekend, with BP shares rising as the oil major planned to return cash to shareholders amid calls by some UK politicians for a windfall profit tax on energy companies.

Read more
3 May 2022 07:53

LONDON MARKET PRE-OPEN: BP swings to quarterly loss after Rosneft exit

(Alliance News) - Stock prices in London are seen opening lower on Tuesday, after the long bank holiday weekend in the UK, as concerns rise over aggressive monetary policy tightening by the US Federal Reserve.

Read more
25 Apr 2022 10:45

AIM WINNERS & LOSERS: musicMagpie sells on new platform; Hutchmed down

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Apr 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 21 April 
Alliance Trust PLCAGM
Ibstock PLCAGM
Journeo PLCAGM
Relx PLCAGM
STV Group PLCAGM
Ruffer Investment Co LtdEGM re share issue
Friday 22 April 
Bellevue Healthcare Trust PLCAGM
Faron Pharmaceuticals LtdAGM
Murray International Trust PLCAGM
Monday 25 April 
Belluscura PLCAGM
Capital Gearing Trust PLCGM re non pre-emptive share issue
Cloudbreak Discovery PLCGM re Crescita equity drawdown agreement
Hikma Pharmaceuticals PLCAGM
JPMorgan US Smaller Cos Investment Trust PLCAGM
Polymetal International PLCAGM
Symphony International Holdings LtdAGM
Tuesday 26 April 
Aquis Exchange PLCAGM
Elementis PLCAGM
GlobalData PLCAGM
Oriole Resources PLCAGM
RPS Group PLCAGM
SigmaRoc PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Wednesday 27 April 
Drax Group PLCAGM
EP Global Opportunities Trust PLCAGM
Global Invacom Group LtdAGM
Hutchmed (China) LtdAGM
London Stock Exchange Group PLCAGM
McKay Securities PLCGM re Workspace offer
Nichols PLCAGM
Persimmon PLCAGM
Primary Health Properties PLCAGM
VH Global Sustainable Energy Opportunities PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.